Skip to Content

  • Search

View Additional Section Content

Chronic Migraine Treatment Trial - The study is to compare the reduction at 6 months in the number of days with severe headache, with a baseline period measured while on topiramate, in participants with chronic migraine treated with topiramate and propranolol, versus those treated with topiramate and placebo.

Principal Investigator(s)
Brad Klein, M.D.
David Weisman, M.D. (Sub-Investigator)

Clinical Trial Categories

  • Headache
Jennifer McGowan at 215-327-0161


  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details